NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-053-1996-0-EP-11 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL CULTURES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTATE CANCER EP DIV 97904061.9 Expired
NCI E-053-1996-0-EP-06 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL CULTURES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTATE CANCER EP National Stage 97904061.5 Abandoned
NIAID E-017-1996-1-US-02 CELLS EXPRESSING BOTH HUMAN CD4 AND A HUMAN FUSION ACCESSORY FACTOR ASSOCIATED WITH HIV INFECTION US ORD 08/791,388 6197578 Expired PDF
NIAID E-017-1996-1-PCT-01 CELLS EXPRESSING BOTH HUMAN CD4 AND CXCR4 PCT PCT COMB PCT/US1997/000956 Expired
NCI E-053-1996-0-PCT-02 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL LINES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTRATE CANCER PCT PCT PCT/US1997/001430 Expired
NCI E-053-1996-0-JP-07 IMMORTAL HUMAN PROSTATE EPITHELIAL CELL LINES AND CLONES AND THEIR APPLICATIONS IN THE RESEARCH AND THERAPY OF PROSTRATE CANCER JP National Stage 1997-527794 Abandoned
NCI E-004-1997-0-US-01 IDENTIFICATION OF A VIRAL ETIOLOGY FOR B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OF CHILDHOOD US 60/036,991 Abandoned
NIDDK E-225-1995-2-HK-06 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. HK National Stage 99102653.6 Abandoned
NIDDK E-225-1995-2-GB-12 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. GB EP 97905627.2 Abandoned
NIDDK E-225-1995-2-FR-11 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. FR EP 97905627.2 Abandoned
NIDDK E-225-1995-2-DE-10 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. DE EP 97905627.2 Abandoned
NIDDK E-225-1995-2-EP-05 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. EP National Stage 97905627.2 Abandoned
NIDDK E-225-1995-2-JP-07 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. JP National Stage 1997-527065 Abandoned
NIDDK E-225-1995-2-CA-03 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. CA National Stage 2244774 Abandoned
NIDDK E-225-1995-2-AU-04 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. AU National Stage 22466/97 Abandoned
NIAID E-185-1994-0-US-08 SERIALLY PASSAGED AFRICAN GREEN MONKEY KIDNEY CELLS WHICH ARE A SUBSTRATE FOR GROWTH OF VIRUSES AND PREPARATION OF VIRAL VACCINES US DIV 08/790,598 5911998 Expired PDF
NIDDK E-225-1995-2-PCT-01 Dihydropyridine-, Pyridine-, Benzopyran- one-, and Triazoloquinazoline Derivative, Their Preparation and Their Use as Adenosine Receptor Antagonists PCT PCT COMB PCT/US1997/001252 Expired
NIDDK E-225-1995-2-EP-09 Dihydropyridine-, Pyridine-, Benzopyranone-, and Triazoloquinazoline Derivatives, Their Preparation and Their Use as Adenosine Receptor Antagonists. EP DIV 10011436.2 Abandoned
NEI E-199-1995-1-PCT-01 HYDROXYLAMINE COMPOSITIONS FOR THE PREVENTION OR RETARDATION OF CATARACTS PCT PCT COMB PCT/US1997/001105 Expired
NCI E-046-1997-0-US-01 AGENTS THAT BIND TO AND INHIBIT HUMAN CYTOCHROME P450 2D6 US ORD 08/788,599 6060253 Expired PDF
NCI E-065-1996-1-US-01 ACRIDONE-DERIVED COMPOUNDS USEFUL AS ANTINEOPLASTIC AND ANTIRETROVIRAL AGENTS US 60/035,050 Abandoned
NCI E-247-1999-0-US-01 Enhancement of Hematopoietic Cells US 60/035,875 Abandoned
NCI E-073-1997-0-US-01 ENHANCED SUPPRESSION OF HIV-1 BY THE COMBINATION OF CYTIDINE NUCLEOSIDE ANALOGUES AND CTP SYNTHASE INHIBITORS. US 60/033,918 Abandoned
NCI E-217-1994-0-US-02 CONFORMATIONALLY CONSTRAINED DIACYLGLYCEROL ANALOGUES US DIV 08/786,660 Abandoned
NCI E-200-1994-1-CA-03 MONOMERIC AND DIMERIC NAPHTHYLISOQUINOLINE ALKALOIDS AND SYNTHESIS METHODS THEREOF CA National Stage 2195647 Abandoned
NHLBI E-286-1988-0-JP-09 PARVOVIRUS CAPSIDS JP DIV 1997-017867 Abandoned
NCI E-028-1990-2-EP-04 VECTOR WITH MULTIPLE TARGET RESPONSE ELEMENTS AFFECTING GENE EXPRESSION EP National Stage 91903122.9 Abandoned
NCI E-218-1984-0-JP-03 Deoxyribonucleic Acid Molecules Useful as Probes for Detecting Oncogenes Incorporated Into Chromosomal DNA... JP DIV 1997-017432 Expired
NHGRI E-012-1997-0-US-01 METHODS FOR DETECTING CERVICAL CANCER US ORD 08/781,424 5919624 Expired PDF
NCI E-245-1994-0-US-06 CHIMERIC PAPILLOMAVIRUS-LIKE PARTICLES US DIV 08/781,084 5855891 Expired PDF
NCI E-047-1994-1-US-01 CIRCULARLY PERMUTATED LIGANDS AND CIRCULARLY PERMUTED CHERMIC MOLECULES US CIP 08/722,258 6011002 Expired PDF
NINDS E-105-1993-1-US-17 USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY US CON 08/780,281 Abandoned
NCI E-257-2008-0-ZA-04 Melanoma Associated Peptide Analogues And Vaccines Against Melanoma ZA National Stage 1997-0005858 Expired
NINDS E-018-1995-0-US-02 PERCUTANEOUS CONNECTOR FOR MULTI-CONDUCTOR ELECTRICAL CABLES US DIV 08/779,639 5782645 Abandoned PDF
NINDS E-105-1993-0-US-24 USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY US CON 08/779,661 Abandoned
NINDS E-105-1993-0-US-25 USE OF NEURO-DERIVED FETAL CELL LINES FOR TRANSPLANTATION THERAPY US CON 08/779,674 Abandoned
NCI E-002-1996-1-CA-04 MESOTHELIN ANTIGEN AND KITS FOR TARGETING IT CA National Stage 2241604 Expired
NCI E-002-1996-1-ES-11 MESOTHELIUM ANTIGEN AND METHODS AND KITS FOR TARGETING IT. ES EP 97902853.7 Expired
NCI E-002-1996-1-DE-08 MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING.. DE EP 97902853.7 Expired
NCI E-002-1996-1-FR-09 MESOTHELIUM ANTIGEN AND METHODS AND KITS FOR TARGETING IT FR EP 97902853.7 Expired
NCI E-002-1996-1-GB-12 MESOTHELIUM ANTIGEN AND METHODS AND KITS FOR TARGETING IT. GB EP 97902853.7 Expired
NCI E-002-1996-1-CH-07 MESOTHELIUM ANTIGEN AND METHODS AND KITS FOR TARGETING IT CH EP 97902853.7 Expired
NCI E-002-1996-1-IT-10 MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING.. IT EP 97902853.7 Expired
NCI E-002-1996-1-EP-05 MESOTHELIUM ANTIGEN AND METHODS AND KITS FOR TARGETING IT. EP National Stage 97902853.7 Expired
NCI E-002-1996-1-AU-03 MESOTHELIN, A DIFFERENTIATION ANTIGEN PRESENT ON MESOTHELIUM, MESOTHELIOMAS AND OVARIAN CANCERS AND METHODS AND KITS FOR TARGETING.. AU National Stage 16927/97 Expired
NCI E-002-1996-1-PCT-01 Mesothelium Antigen and Methods and Kits for Targeting It PCT PCT COMB PCT/US1997/000224 Expired
NCI E-002-1996-1-JP-06 MESOTHELIN ANTIGEN AND METHODS AND KITS FOR TARGETING IT JP National Stage 1997-525355 Abandoned
NCI E-454-1986-3-US-04 Antibodies Against Human Herpesvirus-6(HHV-6) And Method Of Use US DIV 08/774,118 6054283 Expired PDF
NCI E-276-1988-1-US-22 THE DESIGN AND CONSTRUCTION OF NON-INFECTIOUS RETROVIRAL MUTANTS DEFICIENT IN GENOMIC RNA US CON 08/774,054 Abandoned
NCI E-027-1996-0-PCT-02 ENHANCEMENT OF DNA IMMUNIZATION THROUGH THE USE OF CYTOKINES PCT PCT PCT/US1996/020571 Expired